Eikon Therapeutics, Inc. (NASDAQ: EIKN) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT EIKON THERAPEUTICS, INC.

Eikon Therapeutics, Inc. (NASDAQ: EIKN)
Listen to this Section


$10.61
+0.0300 ( +0.28% ) 233.4K

Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.

Market Data


Open $10.61
Previous Close $10.58
Volume 233.4K
Market Cap $572.79M
Day Range $10.22 - $12.00
52 Week Range $7.90 - $17.40
Shares Outstanding 54.14M
Change % +0.28%
Net Change ▲ 0.0300
Insider Ownership N/A
Exchange NASDAQ
Sector
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
IPO Year2026
CountryUnited States
UnderwriterJ.P. Morgan, Morgan Stanley, BofA Securities, Cantor Fitzgerald, Mizuho Securities, more

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


No data available for selected period.

Latest News